ArticleJAMA oncology2018

Estimating and Interpreting the Overall Survival Benefit of Checkpoint Inhibitors via Meta-analysis.

Hajime Uno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.